| 股號 / 名稱 | 營收 | 稅後淨利 |
| NVO 諾和諾德 | 372,560,708,971.93 | 99,411,138,813.65 |
| ABT 美國雅培 | 359,098,104,910.13 | 51,926,931,521.88 |
| MDT 美敦力 | 283,039,679,663.97 | 43,651,471,632.14 |
| SYK 史賽克 | 191,314,734,931.89 | 27,132,137,577.43 |
| BSX Boston Scientific Corp | 159,981,695,960.05 | 23,878,807,926.12 |
| PHG Koninklijke Philips NV | 159,468,148,714.73 | 6,968,854,476.61 |
| ZBH Zimmer Biomet Holdings Inc | 63,215,669,554.68 | 7,302,619,566.82 |
| RMD 瑞思邁 | 42,185,325,459.77 | 11,008,762,168.44 |
| QDEL QuidelOrtho Corp | 22,106,848,766.52 | -23,152,336,256.41 |
| NVST Envista Holdings Corp | 21,159,277,023.42 | -957,047,460.53 |
| BIO Bio Rad Laboratories Inc | 20,625,478,274.81 | -10,799,159,298.86 |
| BRBR Bellring Brands Inc | 20,473,866,795.91 | 1,882,509,196.29 |
| ICUI ICU Medical Inc | 16,961,218,344.24 | -58,591,519.45 |
| EYE National Vision Holdings Inc | 15,392,671,252.16 | 106,507,063.92 |
| PAHC Phibro Animal Health Corp | 11,493,824,143.73 | 837,874,520.97 |
| NEOG Neogen Corp | 7,097,028,084.3 | -502,971,081.24 |
| WRBY Warby Parker Inc | 7,001,923,467.01 | 185,534,547.3 |
| TGTX TG Therapeutics Inc | 5,107,695,966.83 | 12,346,701,883.97 |
| ATRC AtriCure Inc | 4,240,983,679.14 | -8,433,388.51 |
| INMD Inmode Ltd | 2,942,684,048.2 | 690,558,700.65 |
| MGNX MacroGenics Inc | 2,300,672,606.52 | 531,335,062.08 |
| VMD Viemed Healthcare Inc | 2,271,455,811.11 | 113,708,609.17 |
| EOLS Evolus Inc | 2,178,372,680.21 | -497,064,550.71 |
| CERS Cerus Corp | 1,902,629,302.97 | -631,714.5 |
| MRVI Maravai LifeSciences Holdings Inc | 1,314,913,722.18 | -1,423,158,000.96 |
| ZVIA Zevia PBC | 1,290,087,342.51 | -89,956,144.14 |
| QTRX Quanterix Corp | 1,270,788,464.67 | -1,058,658,737.12 |
| INFU InfuSystem Holdings Inc | 1,152,499,925.41 | 71,352,152.26 |
| VALN Valneva SE | 1,090,143,836.72 | -1,644,167,767.61 |
| BLFS BioLife Solutions Inc | 886,516,537.12 | 19,614,735.08 |
| XGN Exagen Inc | 544,664,237.93 | -223,848,031.44 |
| RMTI Rockwell Medical Inc | 503,065,838.41 | -55,369,775.52 |
| APYX Apyx Medical Inc | 406,729,377.86 | -61,750,091.93 |
| MYO Myomo Inc | 318,722,072.94 | -115,695,982.97 |
| IMCC IM Cannabis Corp | 314,404,972.4 | -87,731,948.47 |
| UTMD Utah Medical Products Inc | 309,919,131.44 | 83,102,041.87 |
| FLGC Flora Growth Corp | 307,897,645.06 | -114,561,423.74 |
| CTSO Cytosorbents Corp | 299,590,599.44 | -100,126,747.52 |
| ICCC ImmuCell Corp | 173,914,790.87 | -4,414,105.04 |
| NEPH Nephros Inc | 150,474,392.8 | 10,644,389.25 |
| UG United-Guardian Inc | 71,518,293.17 | 8,478,871.96 |
| SNES Senestech Inc | 21,794,150.09 | -40,998,270.75 |
| GCTK GlucoTrack Inc | 0.0 | -131,744,058.02 |
| PHGE Biomx Inc | 0.0 | -289,514,753.24 |
| OMER Omeros Corp | 0.0 | -670,975,551.29 |
| VERU Veru Inc | 0.0 | 41,192,207.1 |
| CLRB Cellectar Biosciences Inc | 0.0 | -140,363,170.59 |
| CAPR Capricor Therapeutics Inc | 0.0 | -776,081,788.32 |
| ORMP Oramed Pharmaceuticals Inc | 0.0 | 1,528,401,635.9 |
載入數據中...
最新要聞
和醫療產品相關的產業概念股
醫療產品概念股營收排名、龍頭是誰？
醫療產品概念股相關指標排名
醫療產品每月營收
醫療產品每股盈餘
醫療產品每股淨值
醫療產品損益表
醫療產品總資產
醫療產品負債和股東權益
醫療產品現金流量表
醫療產品利潤比率
醫療產品營業費用率拆解
醫療產品杜邦分析
醫療產品ROE / ROA
醫療產品經營週轉能力
醫療產品營運週轉天數
醫療產品現金股利發放率
醫療產品財務結構比率
醫療產品流速動比率
醫療產品利息保障倍數
醫療產品現金流量分析
醫療產品營業現金流對淨利比
醫療產品盈餘再投資比率
醫療產品月營收成長率
醫療產品營收成長率
醫療產品毛利成長率
醫療產品營業利益成長率
醫療產品稅後淨利成長率
醫療產品每股盈餘成長率
醫療產品本益比評價
醫療產品股價淨值比評價
醫療產品現金股利殖利率
醫療產品平均現金股息殖利率
醫療產品董監持股比例
醫療產品董監持股質押比例